: Comprehensive studies to ensure its safe use and to understand any potential environmental implications.
Preclinical Characterization of CDCL-008 (Laurab): A Novel Small-Molecule Modulator for the Treatment of Resistant Inflammatory Pathways cdcl-008 laurab